In 2023, the United States generic injectables market reached an impressive valuation of nearly USD 15.07 billion. This dynamic industry is projected to grow at a steady CAGR of 7% from 2024 to 2032, anticipated to attain a remarkable value of approximately USD 27.76 billion by the end of 2032.
© 2026 Vevioz Enterprise
ꯑꯗꯣꯝꯅꯥ ꯑꯅꯐ꯭ꯔꯦꯟꯗ ꯇꯧꯕꯥ ꯄꯥꯝꯕꯤꯕꯔꯥ?
ꯅꯍꯥꯛꯅꯥ ꯃꯦꯝꯕꯔ ꯑꯁꯤꯕꯨ ꯅꯍꯥꯛꯀꯤ ꯏꯃꯨꯡꯗꯒꯤ ꯂꯧꯊꯣꯀꯄꯥ ꯄꯥꯝꯂꯤꯕ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯅꯍꯥꯛꯅꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯂꯕ꯭ꯔꯥ?
ꯅꯈꯣꯌꯅꯥ ꯄꯣꯀꯄꯥ ꯉꯝꯂꯦ꯫ Jameswilliam5u
ꯑꯅꯧꯕꯥ ꯃꯦꯝꯕꯔ ꯑꯃꯥ ꯑꯗꯣꯃꯒꯤ ꯏꯃꯨꯡꯒꯤ ꯂꯤꯁ꯭ꯇꯇꯥ ꯃꯥꯌ ꯄꯥꯛꯅꯥ ꯍꯥꯄꯆꯤꯜꯂꯦ!
© 2026 Vevioz Enterprise
ꯀꯃꯦꯟꯇ ꯑꯁꯤ ꯃꯥꯌ ꯄꯥꯛꯅꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯈꯤ꯫
ꯄꯣꯁ꯭ꯠ ꯑꯁꯤ ꯑꯗꯣꯃꯒꯤ ꯇꯥꯏꯃꯂꯥꯏꯟꯗꯥ ꯃꯥꯌ ꯄꯥꯛꯅꯥ ꯍꯥꯄꯆꯤꯜꯂꯦ!
ꯑꯗꯣꯝꯅꯥ ꯑꯗꯣꯃꯒꯤ 5000 ꯃꯔꯨꯄꯁꯤꯡꯒꯤ ꯂꯤꯃꯤꯠ ꯑꯗꯨ ꯌꯧꯔꯦ!
ꯐꯥꯏꯜ ꯁꯥꯏꯖꯒꯤ ꯑꯁꯣꯌꯕꯥ: ꯐꯥꯏꯜ ꯑꯗꯨꯅꯥ ꯑꯌꯥꯕꯥ ꯄꯤꯔꯕꯥ ꯂꯤꯃꯤꯠ (2 MB) ꯑꯗꯨꯗꯒꯤ ꯍꯦꯜꯂꯦ ꯑꯃꯁꯨꯡ ꯑꯄꯂꯣꯗ ꯇꯧꯕꯥ ꯉꯃꯗꯦ꯫
ꯐꯥꯏꯜ ꯑꯃꯥ ꯑꯄꯂꯣꯗ ꯇꯧꯕꯥ ꯉꯃꯗꯦ: ꯐꯥꯏꯜ ꯃꯈꯜ ꯑꯁꯤ ꯁꯄꯣꯔꯠ ꯇꯧꯗꯦ꯫
ꯅꯍꯥꯛꯅꯥ ꯑꯄꯂꯣꯗ ꯇꯧꯈꯤꯕꯥ ꯏꯃꯦꯖ ꯑꯗꯨꯗꯥ ꯑꯩꯈꯣꯌꯅꯥ ꯑꯦꯗꯜꯇ ꯀꯟꯇꯦꯟꯇ ꯈꯔꯥ ꯊꯦꯡꯅꯔꯦ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯑꯄꯂꯣꯗ ꯇꯧꯕꯒꯤ ꯊꯧꯑꯣꯡ ꯑꯗꯨ ꯑꯩꯈꯣꯌꯅꯥ ꯌꯥꯗꯔꯦ꯫
ꯏꯃꯦꯖ, ꯚꯤꯗꯤꯑꯣ, ꯑꯃꯁꯨꯡ ꯑꯣꯗꯤꯑꯣ ꯐꯥꯏꯂꯁꯤꯡ ꯑꯄꯂꯣꯗ ꯇꯧꯅꯕꯒꯤꯗꯃꯛ, ꯅꯍꯥꯛꯅꯥ ꯄ꯭ꯔꯣ ꯃꯦꯝꯕꯔꯗꯥ ꯑꯄꯒ꯭ꯔꯦꯗ ꯇꯧꯒꯗꯕꯅꯤ꯫ ꯄ꯭ꯔꯣꯗꯥ ꯑꯄꯒ꯭ꯔꯦꯗ ꯇꯧꯕꯥ꯫